Aslan Pharmaceuticals | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (10)

View All

Latest Posts

About This Stock More About This Stock
The Week Ahead In Biotech (Jan. 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week
Article By: Benzinga
Sunday, January 16, 2022 5:59 PM EDT
Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference. Here are the key catalysts that could move stocks in the unfolding week.
In this article: AZN, ALNY, ISRG, ASLN, CRDF, TYME, MOLN, NXGL, HILS, PBLA
Read
Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal
Article By: ChinaBio® Today
Saturday, October 17, 2020 1:14 PM EDT
Curon Biopharma, a Shanghai clinical-stage in-licensing company, acquired China rights to Tenalisib, a dual PI3K delta and gamma inhibitor, from Rhizen Pharma. Rhizen will receive milestone payments worth up to $149.5 million, plus royalties.
In this article: LLY, LGND, CUE, ASLN, TXG
Read
Week In Review: Suzhou Innovent Raises $300 Million To Develop New Products
Article By: ChinaBio® Today
Saturday, October 5, 2019 3:27 PM EDT
Suzhou Innovent Biologics raised $300 million in a secondary offering to develop three in-licensed products from Incyte and two first-in-class bispecifics.
In this article: ASLN
Read
All Posts

Latest Tweets for $ASLN

No tweets yet!

PARTNER HEADLINES